23andMe (NASDAQ:ME - Get Free Report) issued its earnings results on Tuesday. The company reported ($1.02) EPS for the quarter, Zacks reports. 23andMe had a negative net margin of 183.39% and a negative return on equity of 145.99%.
23andMe Stock Down 9.2 %
NASDAQ ME traded down $0.32 during trading hours on Friday, hitting $3.10. 226,167 shares of the company were exchanged, compared to its average volume of 185,968. 23andMe has a 52-week low of $2.65 and a 52-week high of $16.52. The firm has a market cap of $80.84 million, a price-to-earnings ratio of -0.20 and a beta of 1.14. The company has a 50 day moving average of $3.47 and a two-hundred day moving average of $5.34.
Analysts Set New Price Targets
Separately, Weiss Ratings reiterated a "sell (e+)" rating on shares of 23andMe in a report on Saturday, January 18th.
Check Out Our Latest Stock Report on ME
23andMe Company Profile
(
Get Free Report)
23andMe Holding Co operates as a consumer genetics testing company. The company operates in two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications.
Featured Articles
Before you consider 23andMe, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and 23andMe wasn't on the list.
While 23andMe currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
